Study evaluates costs and benefits of new chemotherapy drugs
18-Mar-2010 -
New chemotherapy agents appear associated with improvements in survival time for patients with metastatic colorectal cancer but at substantial cost. David H. Howard, PhD, and colleagues at Emory University's Rollins School of Public Health (RSPH), used a cancer registry database to measure trends ...
chemotherapy
colon cancer
colorectal cancer
+2